ArticleClinical case reports2025
Comorbidity Between Recurrent Major Depressive Disorder and CADASIL: A Case Report With a Brief Review of Published Cases.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comorbidity Between Recurrent Major Depressive Disorder and CADASIL: A Case Report With a Brief Review of Published Cases.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) may underlie mood disorders by directly affecting cerebral vascular function and neural networks, thereby contributing to or worsening mood symptoms. The co-occurrence of CADASIL and major depressive disorder (MDD) in clinical practice complicates both diagnosis and treatment. We report a case of a 42-year-old woman with an 11-year history of recurrent MDD who presented with atypical depressive symptoms that required hospital admission. Subsequent assessment during hospitalization revealed persistent headaches and abnormal findings on cranial MRI. Given her familial predisposition and previous genetic analysis, a diagnosis of CADASIL was established. After a 3-week course of psychiatric intervention, notable amelioration was observed in both affective and neurological manifestations. The patient demonstrated limited tolerance to psychotropic medications during the treatment. Timely intervention can improve prognosis; however, emotional symptoms may persist, requiring continuous monitoring and management. We also review previously reported CADASIL cases with psychiatric manifestations to provide context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.